Table of Contents
1 Industry Outlook
1.1 Industry Overview
1.2 Total addressable market
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition - Infoholic Research
3.2 Advantages of regenerative medicine
3.3 Disadvantage of regenerative medicine
3.4 Segmented Addressable Market (SAM)
3.5 Trends of the regenerative medicine market
3.6 Related Markets
3.6.1 Wound Biologics
Trends of Wound Biologics market
3.6.2 Stem cell banking
Trends of stem banking market
4 Market Outlook
4.1 Market segmentation
4.2 PEST Analysis
4.3 Porter 5(Five) Forces
5 Market Characteristics
5.1 DRO - Global Regenerative Medicine Market Dynamics
5.1.1 Drivers
5.1.1.1 Increasing incidence of disease
5.1.1.2 Wide application range of regenerative medicine
5.1.1.3 Technological advancement
5.1.2 Opportunities
5.1.2.1 Huge number of ongoing clinical trails and strong portfolio of product pipelin
5.1.2.2 Increased collaboration and partnership
5.1.3 Restraints
5.1.3.1 High treatment cost
5.1.3.2 Ethical issues
5.2 DRO - Impact Analysis
5.3 Key Stakeholders
6 Therapy: Market Size & Analysis
6.1 Overview
6.2 Cell therapy
6.3 Gene Therapy
6.4 Tissue Engineering
6.5 Biologics and Small molecules
7 Applications: Market Size & Analysis
7.1 Overview
7.2 Cancer
7.3 Central Nervous System (CNS)
7.4 Diabetes
7.5 Cardiovascular disease
7.6 Dermatology
7.7 Orthopedic and Musculoskeletal
7.8 Others
8 Regions: Market Size and Analysis
8.1 Overview
8.2 North America
8.2.1 US 40
8.2.2 Canada
8.3 Europe
8.3.1 UK 42
8.3.2 Germany
8.3.3 France
8.3.4 Spain
8.4 Asia Pacific
8.4.1 India
8.4.2 China
8.4.3 Japan
8.5 Rest of the World
9 Competitive Landscape
9.1 Overview
10 Vendor Profiles
10.1 Medtronic Plc
10.1.1 Overview
10.1.2 Business Units
10.1.3 Geographic Presence
10.1.4 Business Focus
10.1.5 SWOT Analysis
10.1.6 Business Strategies
10.2 Organogenesis Inc
10.2.1 Overview
10.2.2 Business Focus
10.2.3 SWOT Analysis
10.2.4 Business Strategies
10.3 Integra Life Sciences Corp.
10.3.1 Overview
10.3.2 Business Units
10.3.3 Geographic Presence
10.3.4 Business Focus
10.3.5 SWOT Analysis
10.3.6 Business Strategies
10.4 MiMedx Group
10.4.1 Overview
10.4.2 Business Focus
10.4.3 SWOT Analysis
10.4.4 Business Strategies
10.5 Zimmer Biomet Holdings' Inc.
10.5.1 Overview
10.5.2 Business Units
10.5.3 Geographic Presence
10.5.4 Business Focus
10.5.5 SWOT Analysis
10.5.6 Business Strategies
11 Companies to Watch for
11.1 Novartis AG
11.1.1 Overview
11.2 Allergan plc
11.2.1 Overview
11.3 Vericel Corporation
11.3.1 Overview
11.4 NuVasive' Inc.
11.4.1 Overview
11.5 Vertex Pharmaceutical Incorporated
11.5.1 Overview
11.6 Acelity LP
11.6.1 Overview
11.7 Osiris Therapeutics' Inc.
11.7.1 Overview
11.7.2 Highlights
Annexure
? Acronyms